These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18362811)

  • 1. How much are Americans willing to pay for a quality-adjusted life year?
    Weinstein MC
    Med Care; 2008 Apr; 46(4):343-5. PubMed ID: 18362811
    [No Abstract]   [Full Text] [Related]  

  • 2. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [QALY or willingness to pay?].
    Steurer J
    Praxis (Bern 1994); 1999 Feb; 88(8):333-8. PubMed ID: 10097643
    [No Abstract]   [Full Text] [Related]  

  • 4. Legislating against use of cost-effectiveness information.
    Neumann PJ; Weinstein MC
    N Engl J Med; 2010 Oct; 363(16):1495-7. PubMed ID: 20942664
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged mechanical ventilation is even more expensive.
    Udeh CI
    Crit Care Med; 2007 Dec; 35(12):2881; author reply 2881-2. PubMed ID: 18043220
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality-adjusted life years: cost-effective medical decision-making.
    Turner S
    J Cardiovasc Manag; 1997; 8(4):34-9. PubMed ID: 10169748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on cost-value analysis.
    Østerdal LP
    Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cost-effectiveness analysis unfair?
    Russell LB
    Med Decis Making; 2004; 24(2):232-4. PubMed ID: 15090108
    [No Abstract]   [Full Text] [Related]  

  • 10. Equity, health, care and values: an economist's perspective.
    Zamagni S
    Dolentium Hominum; 1995; 10(1):203-9. PubMed ID: 15839021
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving fairness in coverage decisions: insights from the Harvard Community Health Plan's LORAN Commission Report.
    Paris JJ
    Am J Bioeth; 2004; 4(3):103-4; discussion W40-2. PubMed ID: 16192160
    [No Abstract]   [Full Text] [Related]  

  • 12. Does willingness to pay per quality-adjusted life year bring us closer to a useful decision rule for cost-effectiveness analysis?
    Polsky D
    Med Decis Making; 2005; 25(6):605-6. PubMed ID: 16282209
    [No Abstract]   [Full Text] [Related]  

  • 13. In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
    Richardson JR; Olsen JA
    Health Econ; 2006 Mar; 15(3):311-3; discussion 319-22. PubMed ID: 16389655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward solving the health care crisis: the paradoxical case for universal access to high technology.
    Satz AB
    Yale J Health Policy Law Ethics; 2008; 8(1):93-143. PubMed ID: 18564494
    [No Abstract]   [Full Text] [Related]  

  • 15. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Østerdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare and cost-effectiveness analysis.
    Berger M; Honig P; Spatz I
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16411304
    [No Abstract]   [Full Text] [Related]  

  • 17. QALYs and policy evaluation: a new perspective.
    Adler MD
    Yale J Health Policy Law Ethics; 2006; 6(1):1-92. PubMed ID: 16480127
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assessment of the value of health-care services--the first step].
    Porzsolt F
    Med Klin (Munich); 2008 May; 103(5):321-4. PubMed ID: 18484218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does assessment of medical practices have a future?
    Capron AM
    Va Law Rev; 1996 Nov; 82(8):1623-40. PubMed ID: 16715566
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.